NDC product
EXTRANEAL
NDC 0941-0679 · Vantive US Healthcare LLC
Key facts
| Product NDC | 0941-0679 |
|---|---|
| Proprietary name | EXTRANEAL |
| Nonproprietary name | icodextrin, sodium chloride, sodium lactate, calcium chloride, magnesium chloride |
| Substances | ICODEXTRIN, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE |
| Dosage form | INJECTION, SOLUTION |
| Route | INTRAPERITONEAL |
| Labeler | Vantive US Healthcare LLC |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Application number | NDA021321 |
| Pharmacologic classes | Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE] and 9 more |
| Marketing start | Dec 20, 2002 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: